Cerevance is a Biotech company based in San Francisco, CA. It has raised $204M in total funding. Latest round: Series B.
Cerevance funding overview
Cerevance is a Biotech company based in San Francisco, CA. Cerevance has raised $204M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2024. The round record for Cerevance runs through 2024; nothing later has been disclosed. Investors on record include Google Ventures, Bill Gates, Casdin Capital, Lightstone Ventures, Foresite Capital, UPMC Enterprises and 6 others. 12 distinct backers are named across the disclosed rounds.
Cerevance at a glance
Total raised
$204M
Latest round
Series B
Latest round date
April 2024
Industry
Biotech
Headquarters
San Francisco, CA
Notable investors
Google Ventures, Bill Gates, Casdin Capital, Lightstone Ventures, Foresite Capital, UPMC Enterprises, Dolby Ventures, Dementia Discovery Fund
Frequently asked about Cerevance funding
How much has Cerevance raised?
Cerevance has raised $204M in total disclosed funding across the rounds on record.
Who has invested in Cerevance?
Google Ventures, Bill Gates, Casdin Capital, Lightstone Ventures, Foresite Capital, UPMC Enterprises are named among the investors backing Cerevance.
What was the latest Cerevance funding round?
The most recent disclosed round is a Series B, announced in April 2024.
Where is Cerevance based?
Cerevance is based in San Francisco, CA.
What sector does Cerevance operate in?
Cerevance is tracked under Biotech from San Francisco, CA, with $204M in disclosed funding.
When did Cerevance last raise?
The last disclosed Cerevance round closed in April 2024 at Series B.
Every Cerevance figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Francisco at a similar stage.
